{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T20:31:42Z","timestamp":1763584302349,"version":"3.45.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s13304-025-02436-2","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T05:51:49Z","timestamp":1760766709000},"page":"2545-2553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lymph-node ratio for micropapillary and nonmicropapillary differentiated thyroid cancers: a comprehensive analysis"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6305-2957","authenticated-orcid":false,"given":"Tugba","family":"Matlim Ozel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husnu","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyma","family":"Karakus Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Cem","family":"Dural","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuri Alper","family":"Sahbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muge","family":"Yurdacan Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Guzey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-2240","authenticated-orcid":false,"given":"Sezer","family":"Akbulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0478-7723","authenticated-orcid":false,"given":"Aykut","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5453-6935","authenticated-orcid":false,"given":"Gorkem","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burak","family":"Guney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozden","family":"Canoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-1776","authenticated-orcid":false,"given":"Serkan","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"issue":"10387","key":"2436_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR (2023) Thyroid cancer. Lancet 401(10387):1531\u20131544. https:\/\/doi.org\/10.1016\/S0140-6736(23)00020-X","journal-title":"Lancet"},{"key":"2436_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejca.2017.02.023","volume":"77","author":"L Dal Maso","year":"2017","unstructured":"Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD et al (2017) EUROCARE-5 working group survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 77:140\u2013152. https:\/\/doi.org\/10.1016\/j.ejca.2017.02.023","journal-title":"Eur J Cancer"},{"issue":"1","key":"2436_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41420-024-02157-2","volume":"10","author":"J Zhang","year":"2024","unstructured":"Zhang J, Xu S (2024) High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks. Cell Death Discov 10(1):378. https:\/\/doi.org\/10.1038\/s41420-024-02157-2","journal-title":"Cell Death Discov"},{"issue":"9","key":"2436_CR4","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/lary.30084","volume":"132","author":"RE Weitzman","year":"2022","unstructured":"Weitzman RE, Justicz NS, Kamani D, Kyriazidis N, Chen MH, Randolph GW (2022) How many nodes to take? Lymph node ratio below 1\/3 reduces papillary thyroid cancer nodal recurrence. Laryngoscope 132(9):1883\u20131887. https:\/\/doi.org\/10.1002\/lary.30084","journal-title":"Laryngoscope"},{"issue":"7","key":"2436_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/bjs.11145","volume":"106","author":"N Chereau","year":"2019","unstructured":"Chereau N, Oyekunle TO, Zambeli-Ljepovi\u0107 A, Kazaure HS, Roman SA, Menegaux F, Sosa JA (2019) Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC\/UICC staging system. Br J Surg 106(7):889\u2013897. https:\/\/doi.org\/10.1002\/bjs.11145","journal-title":"Br J Surg"},{"key":"2436_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.oraloncology.2017.06.004","volume":"71","author":"TH Kim","year":"2017","unstructured":"Kim TH, Kim YN, Kim HI, Park SY, Choe JH, Kim JH et al (2017) Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma. Oral Oncol 71:81\u201386. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.06.004","journal-title":"Oral Oncol"},{"issue":"9","key":"2436_CR7","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1210\/JC.2015-2084","volume":"100","author":"TY Sung","year":"2015","unstructured":"Sung TY, Yoon JH, Hong SJ, Baek JH, Lee JH, Ryu JS, Kim TY et al (2015) Recent changes in the clinical outcome of papillary thyroid carcinoma with cervical lymph node metastasis. J Clin Endocrinol Metab 100(9):3470\u20133477. https:\/\/doi.org\/10.1210\/JC.2015-2084","journal-title":"J Clin Endocrinol Metab"},{"issue":"28","key":"2436_CR8","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1200\/JCO.2016.67.6437","volume":"34","author":"TJ Robinson","year":"2016","unstructured":"Robinson TJ, Thomas S, Dinan MA, Roman S, Sosa JA, Hyslop (2016) How many lymph nodes are enough? Assessing the adequacy of lymph node yield for papillary thyroid cancer. J Clin Oncol 34(28):3434\u20133439. https:\/\/doi.org\/10.1200\/JCO.2016.67.6437","journal-title":"J Clin Oncol"},{"issue":"12","key":"2436_CR9","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s40618-020-01326-1","volume":"43","author":"JW Feng","year":"2020","unstructured":"Feng JW, Ye J, Wu WX et al (2020) Management of cN0 papillary thyroid microcarcinoma patients according to the risk-scoring model for central lymph node metastasis and predictors of recurrence. J Endocrinol Invest 43(12):1807\u20131817. https:\/\/doi.org\/10.1007\/s40618-020-01326-1","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"2436_CR10","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2217\/fon-2020-0993","volume":"17","author":"F Macedo","year":"2021","unstructured":"Macedo F, Sequeira H, Ladeira K, Bonito N, Viana C, Martins S (2021) Metastatic lymph node ratio as a better prognostic tool than the TNM system in colorectal cancer. Future Oncol 17(12):1519\u20131532. https:\/\/doi.org\/10.2217\/fon-2020-0993","journal-title":"Future Oncol"},{"issue":"11","key":"2436_CR11","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1245\/s10434-020-08616-1","volume":"27","author":"K Kano","year":"2020","unstructured":"Kano K, Yamada T, Yamamoto K, Komori K, Watanabe H, Hara K et al (2020) Association between lymph node ratio and survival in patients with pathological stage II\/III gastric cancer. Ann Surg Oncol 27(11):4235\u20134247. https:\/\/doi.org\/10.1245\/s10434-020-08616-1","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"2436_CR12","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1245\/s10434-012-2802-8","volume":"20","author":"DF Schneider","year":"2013","unstructured":"Schneider DF, Chen H, Sippel RS (2013) Impact of lymph node ratio on survival in papillary thyroid cancer. Ann Surg Oncol 20(6):1906\u20131911. https:\/\/doi.org\/10.1245\/s10434-012-2802-8","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2436_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/jamaoto.2017.2416","volume":"144","author":"M Amit","year":"2018","unstructured":"Amit M, Tam S, Boonsripitayanon M, Cabanillas ME, Busaidy NL et al (2018) Association of lymph node density with survival of patients with Papillary thyroid cancer. JAMA Otolaryngol Head Neck Surg 144(2):108\u2013114. https:\/\/doi.org\/10.1001\/jamaoto.2017.2416","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"5","key":"2436_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002692","volume":"95","author":"SG Lee","year":"2016","unstructured":"Lee SG, Ho J, Choi JB, Kim TH, Kim MJ, Ban EJ et al (2016) Optimal cut-off values of lymph node ratio predicting recurrence in papillary thyroid cancer. Medicine (Baltimore) 95(5):e2692. https:\/\/doi.org\/10.1097\/MD.0000000000002692","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"2436_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1089\/thy.2012.0329","volume":"23","author":"BY Cho","year":"2013","unstructured":"Cho BY, Choi HS, Park YJ, Lim JA, Ahn HY, Lee EK et al (2013) Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid 23(7):797\u2013804. https:\/\/doi.org\/10.1089\/thy.2012.0329","journal-title":"Thyroid"},{"key":"2436_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3389\/fendo.2020.00551","volume":"11","author":"F Medas","year":"2020","unstructured":"Medas F, Canu GL, Cappellacci F, Boi F, Lai ML, Erdas E, Cal\u00f2 PG (2020) Predictive factors of lymph node metastasis in patients with papillary microcarcinoma of the thyroid: retrospective analysis on 293 cases. Front Endocrinol 11:551. https:\/\/doi.org\/10.3389\/fendo.2020.00551","journal-title":"Front Endocrinol"},{"issue":"12","key":"2436_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.4158\/EP-2018-0305","volume":"24","author":"X Wu","year":"2018","unstructured":"Wu X, Li B, Zheng C, He X (2018) Risk factors for central lymph node metastases in patients with Papillary thyroid microcarcinoma. Endocr Pract 24(12):1057\u20131062. https:\/\/doi.org\/10.4158\/EP-2018-0305","journal-title":"Endocr Pract"},{"issue":"6","key":"2436_CR18","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1210\/clinem\/dgac739","volume":"108","author":"JS Lee","year":"2023","unstructured":"Lee JS, Lee JS, Yun HJ, Kim SM, Chang H, Lee YS et al (2023) Aggressive subtypes of papillary thyroid carcinoma smaller than 1 cm. J Clin Endocrinol Metab 108(6):1370\u20131375. https:\/\/doi.org\/10.1210\/clinem\/dgac739","journal-title":"J Clin Endocrinol Metab"},{"key":"2436_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"key":"2436_CR20","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK et al (2017) AJCC cancer staging manual, 8th edn. Springer, New York","edition":"8"},{"issue":"11","key":"2436_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15112947","volume":"15","author":"IK Kang","year":"2023","unstructured":"Kang IK, Park J, Bae JS, Kim JS, Kim K (2023) Lymph node ratio predicts recurrence in patients with Papillary thyroid carcinoma with low lymph node yield. Cancers (Basel) 15(11):2947. https:\/\/doi.org\/10.3390\/cancers15112947","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2436_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/thy.2017.0227","volume":"28","author":"A Miyauchi","year":"2018","unstructured":"Miyauchi A, Ito Y, Oda H (2018) Insights into the management of Papillary Microcarcinoma of the thyroid. Thyroid 28(1):23\u201331. https:\/\/doi.org\/10.1089\/thy.2017.0227","journal-title":"Thyroid"},{"issue":"4","key":"2436_CR23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.21037\/gs-20-273","volume":"9","author":"L Zhou","year":"2020","unstructured":"Zhou L, Li Q, Chen S, Huang Y, Wei W, Zhang C et al (2020) Synergic effects of histology subtype, lymph node metastasis, and distant metastasis on prognosis in differentiated thyroid carcinoma using the SEER database. Gland Surg 9(4):907\u2013918. https:\/\/doi.org\/10.21037\/gs-20-273","journal-title":"Gland Surg"},{"key":"2436_CR24","doi-asserted-by":"publisher","first-page":"1026737","DOI":"10.3389\/fendo.2022.1026737","volume":"13","author":"YG Sun","year":"2022","unstructured":"Sun YG, Chen F, Sun QL, Tian JY, He XC (2022) The number of metastatic lymph nodes optimizes staging in patients aged 55 years or older with papillary thyroid cancer. Front Endocrinol 13:1026737. https:\/\/doi.org\/10.3389\/fendo.2022.1026737","journal-title":"Front Endocrinol"},{"key":"2436_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.oraloncology.2016.12.028","volume":"66","author":"Y Sun","year":"2017","unstructured":"Sun Y, Liu X, Ouyang W, Feng H, Wu J, Chen P, Wang J (2017) Lymph-node characteristics for predicting locoregional recurrence of papillary thyroid cancer in adolescents and young adults. Oral Oncol 66:22\u201327. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.12.028","journal-title":"Oral Oncol"},{"issue":"11","key":"2436_CR26","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1089\/thy.2012.0043","volume":"22","author":"GW Randolph","year":"2012","unstructured":"Randolph GW, Duh QY, Heller KS et al (2012) American thyroid association surgical affair committee\u2019s taskforce on thyroid cancer nodal surgery. the prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22(11):1144\u20131152. https:\/\/doi.org\/10.1089\/thy.2012.0043","journal-title":"Thyroid"},{"issue":"1","key":"2436_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.21053\/ceo.2016.9.1.75","volume":"9","author":"SY Choi","year":"2016","unstructured":"Choi SY, Cho JK, Moon JH, Son YI (2016) Metastatic lymph node ratio of central neck compartment has predictive values for locoregional recurrence in papillary thyroid microcarcinoma. Clin Exp Otorhinolaryngol 9(1):75\u201379. https:\/\/doi.org\/10.21053\/ceo.2016.9.1.75","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"2","key":"2436_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1634\/theoncologist.2012-0240","volume":"18","author":"DF Schneider","year":"2013","unstructured":"Schneider DF, Mazeh H, Chen H, Sippel RS (2013) Lymph-node ratio predicts recurrence in papillary thyroid cancer. Oncologist 18(2):157\u2013162. https:\/\/doi.org\/10.1634\/theoncologist.2012-0240","journal-title":"Oncologist"},{"issue":"2","key":"2436_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.surg.2016.07.031","volume":"161","author":"YC Lee","year":"2017","unstructured":"Lee YC, Na SY, Park GC, Han JH, Kim SW, Eun YG (2017) Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: a multi-institutional study. Surgery 161(2):465\u2013471. https:\/\/doi.org\/10.1016\/j.surg.2016.07.031","journal-title":"Surgery"},{"issue":"1","key":"2436_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50069-4","volume":"9","author":"J Lee","year":"2019","unstructured":"Lee J, Lee SG, Kim K, Yim SH, Ryu H, Lee CR et al (2019) Clinical value of lymph node ratio integration with the 8th edition of the UICC TNM classification and 2015 ATA risk stratification systems for recurrence prediction in papillary thyroid cancer. Sci Rep 9(1):13361. https:\/\/doi.org\/10.1038\/s41598-019-50069-4","journal-title":"Sci Rep"},{"issue":"2","key":"2436_CR31","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0518","volume":"11","author":"SK Parvathareddy","year":"2022","unstructured":"Parvathareddy SK, Siraj AK, Qadri Z, Ahmed SO, DeVera F, Al-Sobhi S et al (2022) Lymph-node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma. Endocr Connect 11(2):e210518. https:\/\/doi.org\/10.1530\/EC-21-0518","journal-title":"Endocr Connect"},{"issue":"4","key":"2436_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.asjsur.2015.02.006","volume":"39","author":"YW Chang","year":"2016","unstructured":"Chang YW, Kim HS, Kim HY, Lee JB, Bae JW, Son GS (2016) Should central lymph node dissection be considered for all papillary thyroid microcarcinoma? Asian J Surg 39(4):197\u2013201. https:\/\/doi.org\/10.1016\/j.asjsur.2015.02.006","journal-title":"Asian J Surg"},{"issue":"4","key":"2436_CR33","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1210\/jc.2011-1546","volume":"97","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wei WJ, Ji QH, Zhu YX, Wang ZY, Wang Y et al (2012) Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab 97(4):1250\u20131257. https:\/\/doi.org\/10.1210\/jc.2011-1546","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2436_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0039-6060(03)00384-2","volume":"135","author":"I Sugitani","year":"2004","unstructured":"Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A (2004) A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135(2):139\u2013148. https:\/\/doi.org\/10.1016\/s0039-6060(03)00384-2","journal-title":"Surgery"},{"issue":"1","key":"2436_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.21053\/ceo.2017.00472","volume":"11","author":"CM Zheng","year":"2018","unstructured":"Zheng CM, Ji YB, Song CM, Ge MH (2018) Number of metastatic lymph nodes and ratio of metastatic lymph nodes to total number of retrieved lymph nodes are risk factors for recurrence in patients with clinically node negative papillary thyroid carcinoma. Clin Exp Otorhinolaryngol 11(1):58\u201364. https:\/\/doi.org\/10.21053\/ceo.2017.00472. (Tae K)","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"2","key":"2436_CR36","first-page":"159","volume":"21","author":"M Appetecchia","year":"2002","unstructured":"Appetecchia M, Scarcello G, Pucci E, Procaccini A (2002) Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res 21(2):159\u2013164 (PMID: 12148571)","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2436_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/cncr.11442","volume":"98","author":"SM Chow","year":"2003","unstructured":"Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH (2003) Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer 98(1):31\u201340. https:\/\/doi.org\/10.1002\/cncr.11442","journal-title":"Cancer"},{"issue":"2","key":"2436_CR38","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1210\/jc.2016-2287","volume":"102","author":"Y Hwangbo","year":"2017","unstructured":"Hwangbo Y, Kim JM, Park YJ, Lee EK, Lee YJ, Park DJ et al (2017) Long-term recurrence of small papillary thyroid cancer and its risk factors in a Korean multicenter study. J Clin Endocrinol Metab 102(2):625\u2013633. https:\/\/doi.org\/10.1210\/jc.2016-2287","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02436-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02436-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02436-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T20:02:35Z","timestamp":1763582555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-025-02436-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2436"],"URL":"https:\/\/doi.org\/10.1007\/s13304-025-02436-2","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"type":"print","value":"2038-131X"},{"type":"electronic","value":"2038-3312"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"14 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures conducted in this study that involved human subjects were in accordance with the ethical standards depicted by the local ethics committee of the Basaksehir Cam and Sakura Health Practices and Research Center (EK- 2021.03.10) with the 1964 Helsinki Declaration and later amendments and compatible ethical standards. The studies were conducted in accordance with local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants\u2019 legal guardians\/next of kin in accordance with the national legislation and institutional requirements. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This retrospective study was conducted in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration  and its later amendments or comparable ethical standards. Ethical approval was obtained from the respective institutional review boards. No animal experiments were performed as part of this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights Statement"}},{"value":"Informed consent for the use of clinical and pathological data for research purposes was obtained from all patients at the time of surgery or hospital admission.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}